Reflections on the Future of Cardiovascular Protection in Vascular Surgery

We are grateful for the detailed and insightful comments by Joakim Nordanstig1 addressing our recent publication about the association between antithrombotic and lipid lowering therapy and improved survival after vascular surgery in Norway.2 We completely agree that optimal medical management goes far beyond the prescription of aspirin and statin and agree with all the examples given in the last paragraph regarding antithrombotic treatment, dyslipidaemia management, and antidiabetic therapies.
Source: European Journal of Vascular and Endovascular Surgery - Category: Surgery Authors: Tags: Letter to the Editor Source Type: research